Fortress Biotech, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Fortress Biotech, Inc. (FBIO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $13.62 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2019-03-18
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2017-12-31 was $0.00.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2017-09-30 was $0.00.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2017-06-30 was $544.00K.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2017 was $750.00K, a 5.42% decline from fiscal 2016.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $793.00K, a 29.36% increase from fiscal 2015.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $613.00K.
- Fortress Biotech, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $2.69M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $13.62M 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | $13.62M 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $544.00K derived: sum of 3 quarters · filed 2019-03-18 | $750.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $544.00K derived: sum of 2 quarters · filed 2017-11-09 | $750.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $750.00K 10-Q · filed 2017-08-09 | ||
| 2017-03-31 | $206.00K 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $793.00K 10-K · filed 2018-03-16 | |||
| 2015-12-31 | $613.00K 10-K · filed 2018-03-16 | |||
| 2011-12-31 | $2.69M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |